Physician

Rohit Sundrani, M.D., FACC, FSCAI

According to 2025 Medicare claims, Rohit Sundrani, M.D., FACC, FSCAI (NPI: 1508835463) practices interventional cardiology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is CARDIOVASCULAR CONSULTANTS OF FRESNO, A PROFESSIONAL CORPORATION (NPI: 1497724355; TIN: 942686822) and primary practice location at 93720-3235.

Sundrani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 4,519 traditional Medicare patients, billed 18,889 HCPCS/CPT codes, and received $1,950,051 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 13,789 prescription claims across 2,176 beneficiaries totaling $2,231,488 in drug costs, led by Xarelto (Rivaroxaban). DME data shows 36 claims. Open Payments data shows 44 records totaling $8,792. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $831,935 to $2,231,488. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,903 to $1,032.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,575	16,584	$1,966,641
2016	3,104	14,678	$1,705,031
2017	2,914	12,890	$1,327,175
2018	3,095	15,441	$1,434,807
2019	2,983	15,799	$1,509,001
2020	2,615	14,961	$1,522,758
2021	2,939	15,780	$1,529,810
2022	3,733	16,941	$1,399,720
2023	4,066	17,295	$1,509,948
2024	4,519	18,889	$1,950,051

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,146	12,415	$831,935
2016	1,238	13,101	$948,308
2017	1,305	12,781	$1,060,407
2018	1,413	12,977	$1,355,337
2019	1,491	12,046	$1,601,482
2020	1,597	12,329	$1,627,666
2021	1,672	11,698	$1,594,274
2022	1,784	10,717	$1,540,583
2023	1,749	9,839	$1,616,271
2024	2,176	13,789	$2,231,488

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	60	$2,786
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$253
2019	N/R	N/R	N/R
2020	N/R	26	$1,066
2021	N/R	38	$1,583
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	12	36	$2,264

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,236	1,291	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,516	2,649	$94
99442	Telephone medical discussion with physician, 11-20 minutes	851	975	$71
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,148	1,317	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,413	2,942	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	674	47,895	$872,344
Eliquis	Apixaban	396	26,412	$505,464
Entresto	Sacubitril/Valsartan	138	8,902	$195,414
Farxiga	Dapagliflozin Propanediol	124	6,450	$115,360
Repatha Sureclick	Evolocumab	114	5,152	$96,942

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L3660	Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf	N	12	12	$1,232
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$676
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$356

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$6,077	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$2,715	Abbott Laboratories
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rohit Sundrani, M.D., FACC, FSCAI?

Tedicare shows public-source Medicare data for Rohit Sundrani, M.D., FACC, FSCAI (NPI 1508835463), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rohit Sundrani, M.D., FACC, FSCAI have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rohit Sundrani, M.D., FACC, FSCAI?

Rohit Sundrani, M.D., FACC, FSCAI is linked to CARDIOVASCULAR CONSULTANTS OF FRESNO, A PROFESSIONAL CORPORATION (billing NPI 1497724355) in the available physician profile data.

Does Rohit Sundrani, M.D., FACC, FSCAI have Open Payments data?

Rohit Sundrani, M.D., FACC, FSCAI has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.